Headquarters: Basel, Switzerland
CEO: Dr. Christoph Bronnimann
CHF as of July 1, 2023
|Company||Market Cap (USD)|
|Stryker Corporation||$111.71 B|
|Boston Scientific Corporation||$75.41 B|
|Edwards Lifesciences Corporation||$56.44 B|
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
Medartis Holding AG has the following listings and related stock indices.
Stock: SIX: MED